ORTHOCELL LIMITED

1.67%

88.5¢

Market Cap $244.1M

Healthcare Biotechnology

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is an acellular resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen-based nerve wrap designed to support nerve repair surgery in peripheral nerve repair. OrthoACI, or Autologous Chondrocyte Implantation, offers treatment for symptomatic defects of the articulating cartilage of the joints. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Inside Racura Oncology (ASX:RAC): Strategy, Clinical Milestones and 2026 outlook.

Latest Threads

Tag

Subject

OCC

Media thread

21 22 23

22:22

1.3K

521K

22:22

Last post FreeFromStyle

1.3K

521K

OCC

OCC Broker Data

4 5 6

16:53

315

145K

16:53

Last post stevieg999

315

145K

OCC

Ann: Appendix 3Y - John Van Der Wielen

10:48

3.6K

10:48

Last post bedger

3.6K

OCC

OCC chart

46 47 48

28/02/26

2.8K

1.3M

28/02/26

Last post scolloymore

2.8K

1.3M

OCC

Upcoming Catalysts

26/02/26

1.1K

26/02/26

Last post saltland

1.1K

OCC

Ann: Appendix 3Y - Michael McNulty

26/02/26

268

26/02/26

Last post

ASX News

268

OCC

Ann: Appendix 4D & Half-Year Financial Report

25/02/26

5.4K

25/02/26

Last post FreeFromStyle

5.4K

OCC

Marine Biomedical Submits 510(k) Application to the U.S. FDA for PearlBone™

23/02/26

8.8K

23/02/26

Last post scolloymore

8.8K

See All Discussions

Timeline

Appendix 3Y - Michael McNulty
26 Feb 08:47	Share

Appendix 3Y - John Van Der Wielen
26 Feb 08:46	Share

Appendix 4D & Half-Year Financial Report
24 Feb 09:02	Share

Orthocell Receives $3.0m R&D Tax Refund
18 Feb 12:56	Share

US Market and Operational Update
02 Feb 09:02	Share

Orthocell Investor Webinar Details
29 Jan 10:21	Share

Quarterly Activity Report & Appendix 4C
19 Jan 09:07	Share

Orthocell Finalises Strategic Investment in Marine Biomedica
16 Jan 09:01	Share

Orthocell Posts Seventh Straight Record Revenue Quarter
06 Jan 09:33	Share

Appendix 3Y - Paul Anderson
22 Dec 18:10	Share

Cleansing Notice
22 Dec 18:06	Share

Application for quotation of securities - OCC
22 Dec 18:04	Share

Orthocell Hits US Milestone - 100 Remplir Units Sold.
18 Dec 09:42	Share

Remplir Regulatory Application for US$750m EU-UK Market
15 Dec 09:05	Share

First Commercial Sales of Remplir Achieved in Hong Kong
10 Dec 09:18	Share

Appendix 3Y - Paul Anderson
28 Nov 18:28	Share

Notification regarding unquoted securities - OCC
28 Nov 18:24	Share

Remplir gains momentum in nerve-sparing prostate surgery
20 Nov 09:03	Share

Cleansing Notice
14 Nov 13:24	Share

Application for quotation of securities - OCC
14 Nov 13:20	Share

Amended Constitution
06 Nov 18:25	Share

Results of Annual General Meeting
06 Nov 14:50	Share

AGM Addresses by Chair and Managing Director
06 Nov 09:30	Share

2nd Distributor in Canada, Entire $75m Market Now Covered
05 Nov 08:59	Share

Remplir Launches in Hong Kong with First Surgical Case
03 Nov 09:12	Share

Appendix 3Y - Michael McNulty
31 Oct 09:03	Share

Appendix 3Y - John Van Der Wielen
31 Oct 08:59	Share

HK Distributor Signed as Remplir Expands in the Asian Market
29 Oct 08:57	Share

Notification regarding unquoted securities - OCC
24 Oct 09:50	Share

Cleansing Notice
24 Oct 09:50	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 88.5¢		Change -0.015(1.67%)		Mkt cap ! $244.1M

Open	High	Low	Volume
90.0¢	90.0¢	87.5¢	346.2K

Buyers (Bids)

Vol.	Price($)
5977	88.5¢

Sellers (Offers)

Price($)	Vol.
90.0¢	35575

Last trade - 16.10pm 06/03/2026 (20 minute delay)

OCC (ASX) Chart

ORTHOCELL LIMITED

Latest Threads

NEW DealRoom Raise Dropping TODAY

Timeline

Featured News

Latest Videos

Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come

04 Dec 2024 15:54 (AEDT)

Latest Articles

Orthocell pops on nerve healing successes in prostate surgery patients

Orthocell has seen its share price jump on Thursday as the company unveils its latest early-stage successes.

Orthocell coughs up $1M for 12% stake in WA biotech using pearl shells to create bone healing matrix

Orthocell Ltd has boosted its stake in a Western Australia-based biotech company called 'PearlBone,' which uses nacre.

Orthocell jumps as nerve repair tech shows hope for erectile dysfunction post-prostate surgery

Orthocell shares popped +10% as the company reported its flagship nerve repair product, Remplir, is being used by Australian urologists.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News